ID   GSP_ECOLI               Reviewed;         619 AA.
AC   P0AES0; P43675; Q2M9K7;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   15-FEB-2017, entry version 94.
DE   RecName: Full=Bifunctional glutathionylspermidine synthetase/amidase;
DE            Short=GspSA;
DE   Includes:
DE     RecName: Full=Glutathionylspermidine amidase;
DE              Short=Gsp amidase;
DE              EC=3.5.1.78 {ECO:0000269|PubMed:20530482, ECO:0000269|PubMed:23097746, ECO:0000269|PubMed:7775463, ECO:0000269|PubMed:8999955};
DE     AltName: Full=Glutathionylspermidine amidohydrolase [spermidine-forming];
DE   Includes:
DE     RecName: Full=Glutathionylspermidine synthetase;
DE              Short=Gsp synthetase;
DE              EC=6.3.1.8 {ECO:0000269|PubMed:20530482, ECO:0000269|PubMed:23097746, ECO:0000269|PubMed:7775463, ECO:0000269|PubMed:8999955};
DE     AltName: Full=Glutathione:spermidine ligase [ADP-forming];
DE     AltName: Full=Gsp synthase;
GN   Name=gss; Synonyms=gsp; OrderedLocusNames=b2988, JW2956;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-7, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RC   STRAIN=B, and K12;
RX   PubMed=7775463; DOI=10.1074/jbc.270.23.14031;
RA   Bollinger J.M. Jr., Kwon D.S., Huisman G.W., Kolter R., Walsh C.T.;
RT   "Glutathionylspermidine metabolism in Escherichia coli. Purification,
RT   cloning, overproduction, and characterization of a bifunctional
RT   glutathionylspermidine synthetase/amidase.";
RL   J. Biol. Chem. 270:14031-14041(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   REACTION MECHANISM OF AMIDASE ACTIVITY, ACTIVE SITE AT CYS-59, ENZYME
RP   REGULATION, AND MUTAGENESIS OF CYS-59 AND CYS-173.
RX   PubMed=9398217; DOI=10.1021/bi9714464;
RA   Lin C.H., Kwon D.S., Bollinger J.M. Jr., Walsh C.T.;
RT   "Evidence for a glutathionyl-enzyme intermediate in the amidase
RT   activity of the bifunctional glutathionylspermidine synthetase/amidase
RT   from Escherichia coli.";
RL   Biochemistry 36:14930-14938(1997).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, DOMAIN, SUBSTRATE SPECIFICITY, AND
RP   ENZYME REGULATION.
RX   PubMed=8999955; DOI=10.1074/jbc.272.4.2429;
RA   Kwon D.S., Lin C.H., Chen S., Coward J.K., Walsh C.T.,
RA   Bollinger J.M. Jr.;
RT   "Dissection of glutathionylspermidine synthetase/amidase from
RT   Escherichia coli into autonomously folding and functional synthetase
RT   and amidase domains.";
RL   J. Biol. Chem. 272:2429-2436(1997).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12;
RX   PubMed=23097746;
RA   Sui L., Warren J.C., Russell J.P., Stourman N.V.;
RT   "Comparison of the functions of glutathionylspermidine
RT   synthetase/amidase from E. coli and its predicted homologues YgiC and
RT   YjfC.";
RL   Int. J. Biochem. Mol. Biol. 3:302-312(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF APOENZYME AND IN COMPLEXES
RP   WITH SUBSTRATE; PRODUCT AND INHIBITOR, DOMAIN BOUNDARIES, SUBUNIT,
RP   REACTION MECHANISM OF SYNTHETASE ACTIVITY, KINETIC PARAMETERS, SITE AT
RP   ARG-316, AND MUTAGENESIS OF SER-335; SER-337; CYS-338; GLU-391;
RP   GLU-392; THR-441; ARG-538 AND ARG-598.
RX   PubMed=17124497; DOI=10.1038/sj.emboj.7601440;
RA   Pai C.H., Chiang B.Y., Ko T.P., Chou C.C., Chong C.M., Yen F.J.,
RA   Chen S., Coward J.K., Wang A.H., Lin C.H.;
RT   "Dual binding sites for translocation catalysis by Escherichia coli
RT   glutathionylspermidine synthetase.";
RL   EMBO J. 25:5970-5982(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 1-197, FUNCTION, ROLE IN
RP   REDOX REGULATION, CATALYTIC ACTIVITY, ENZYME REGULATION, OXIDATION AT
RP   CYS-59, AND DISRUPTION PHENOTYPE.
RX   PubMed=20530482; DOI=10.1074/jbc.M110.133363;
RA   Chiang B.Y., Chen T.C., Pai C.H., Chou C.C., Chen H.H., Ko T.P.,
RA   Hsu W.H., Chang C.Y., Wu W.F., Wang A.H., Lin C.H.;
RT   "Protein S-thiolation by glutathionylspermidine (Gsp): the role of
RT   Escherichia coli Gsp synthetase/amidase in redox regulation.";
RL   J. Biol. Chem. 285:25345-25353(2010).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF MUTANT ALA-59 IN COMPLEXES
RP   WITH ADP; GLUTATHIONYLSPERMIDINE AND MAGNESIUM, ACTIVE SITES, AND
RP   CATALYTIC MECHANISM OF AMIDASE ACTIVITY.
RX   PubMed=21226054; DOI=10.1002/pro.589;
RA   Pai C.H., Wu H.J., Lin C.H., Wang A.H.;
RT   "Structure and mechanism of Escherichia coli glutathionylspermidine
RT   amidase belonging to the family of cysteine; histidine-dependent
RT   amidohydrolases/peptidases.";
RL   Protein Sci. 20:557-566(2011).
CC   -!- FUNCTION: Catalyzes the formation of an amide bond between
CC       glutathione (GSH) and spermidine coupled with hydrolysis of ATP;
CC       also catalyzes the opposing reaction, i.e. the hydrolysis of
CC       glutathionylspermidine (Gsp) back to glutathione and spermidine.
CC       The amidase active site can also hydrolyze Gsp-disulfide (Gsp-S-S-
CC       Gsp) to Gsp-SG and Gsp S-thiolated proteins (GspSSPs) to GSH S-
CC       thiolated protein (GSSPs). Likely acts synergistically with
CC       glutaredoxin to regulate the redox environment of E.coli and
CC       defend against oxidative damage. In vitro, the amidase active site
CC       also catalyzes hydrolysis of amide and ester derivatives of
CC       glutathione (e.g. glutathione ethyl ester and glutathione amide)
CC       but lacks activity toward acetylspermidine (N1 and N8) and
CC       acetylspermine (N1). {ECO:0000269|PubMed:20530482,
CC       ECO:0000269|PubMed:23097746, ECO:0000269|PubMed:7775463,
CC       ECO:0000269|PubMed:8999955}.
CC   -!- CATALYTIC ACTIVITY: Glutathione + spermidine + ATP =
CC       glutathionylspermidine + ADP + phosphate.
CC       {ECO:0000269|PubMed:20530482, ECO:0000269|PubMed:23097746,
CC       ECO:0000269|PubMed:7775463, ECO:0000269|PubMed:8999955}.
CC   -!- CATALYTIC ACTIVITY: Glutathionylspermidine + H(2)O = glutathione +
CC       spermidine. {ECO:0000269|PubMed:20530482,
CC       ECO:0000269|PubMed:23097746, ECO:0000269|PubMed:7775463,
CC       ECO:0000269|PubMed:8999955}.
CC   -!- ENZYME REGULATION: When exposed to oxidative stress, Gsp amidase
CC       activity is transiently inhibited in vivo by oxidation of the
CC       catalytic Cys-59 thiol to sulfenic acid; this modification does
CC       not affect Gsp synthetase activity. Gsp amidase activity is
CC       negatively autoregulated by the Gsp synthetase domain, and is
CC       activated by the Gsp synthetase substrates, GSH and ATP-Mg(2+);
CC       the occupancy of the synthetase active site may initiate
CC       communication through the protein as manifest by the release of
CC       inhibition of the amidase activity. A tetrahedral phosphonate
CC       analog of glutathionylspermidine, designed as a mimic of the
CC       proposed tetrahedral intermediate for either reaction, inhibits
CC       the synthetase activity (Ki of 10 uM) but does not inhibit the
CC       amidase activity. Amidase activity is inhibited by iodoacetamide
CC       in vitro. {ECO:0000269|PubMed:20530482,
CC       ECO:0000269|PubMed:8999955, ECO:0000269|PubMed:9398217}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=100 uM for ATP (at pH 6.8) {ECO:0000269|PubMed:17124497,
CC         ECO:0000269|PubMed:7775463};
CC         KM=800 uM for glutathione (at pH 6.8)
CC         {ECO:0000269|PubMed:17124497, ECO:0000269|PubMed:7775463};
CC         KM=218 uM for glutathione {ECO:0000269|PubMed:17124497,
CC         ECO:0000269|PubMed:7775463};
CC         KM=60 uM for spermidine (at pH 6.8)
CC         {ECO:0000269|PubMed:17124497, ECO:0000269|PubMed:7775463};
CC         KM=20 uM for spermidine (at pH 7.5)
CC         {ECO:0000269|PubMed:17124497, ECO:0000269|PubMed:7775463};
CC         KM=76 uM for spermidine {ECO:0000269|PubMed:17124497,
CC         ECO:0000269|PubMed:7775463};
CC         KM=900 uM for glutathionylspermidine (at pH 7.5)
CC         {ECO:0000269|PubMed:17124497, ECO:0000269|PubMed:7775463};
CC         Note=kcat is 7 sec(-1) for Gsp synthetase activity at pH 6.8 and
CC         2.1 sec(-1) for Gsp amidase activity at pH 7.5.
CC         {ECO:0000269|PubMed:7775463};
CC       pH dependence:
CC         Optimum pH is around 6.8 for Gsp synthetase activity.
CC         {ECO:0000269|PubMed:7775463};
CC   -!- PATHWAY: Sulfur metabolism; glutathione metabolism.
CC   -!- PATHWAY: Amine and polyamine metabolism; spermidine metabolism.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17124497,
CC       ECO:0000269|PubMed:7775463}.
CC   -!- INTERACTION:
CC       P31574:fixB; NbExp=2; IntAct=EBI-557080, EBI-554030;
CC       P0AG30:rho; NbExp=4; IntAct=EBI-557080, EBI-545468;
CC   -!- INDUCTION: Expression level is unaffected by H(2)O(2); however Gsp
CC       rapidly accumulates in E.coli in the presence of H(2)O(2).
CC   -!- DOMAIN: The two activities reside in distinct domains (N-terminal
CC       amidase and C-terminal synthetase). The two domains expressed
CC       independently are folded and functional; liberation of the amidase
CC       domain from the synthetase domain highly activates the amidase
CC       activity. {ECO:0000269|PubMed:17124497,
CC       ECO:0000269|PubMed:8999955}.
CC   -!- PTM: Oxidation of Cys-59 to sulfenic acid during oxidative stress
CC       selectively inhibits the amidase activity which leads to a rapid
CC       increase in the amounts of intracellular Gsp and Gsp S-thiolated
CC       proteins (GspSSPs). {ECO:0000269|PubMed:20530482}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene do not produce Gsp
CC       under anaerobic conditions. Cells lacking both this gene and
CC       glutaredoxin (grxA or grxB) become hypersensitive to H(2)O(2);
CC       they are even more susceptible to oxidative damage than the single
CC       mutant lacking glutaredoxin only. {ECO:0000269|PubMed:20530482,
CC       ECO:0000269|PubMed:23097746}.
CC   -!- MISCELLANEOUS: Gsp forms mixed disulfides with the thiols of a
CC       variety of E.coli proteins. These mixed disulfides represent a
CC       previously uncharacterized type of post-translational
CC       modification. The level of these proteins is increased by
CC       oxidative stress, which implies that Gsp might protect protein
CC       thiols against irreversible oxidation (PubMed:20530482).
CC       {ECO:0000305|PubMed:20530482}.
CC   -!- MISCELLANEOUS: No metal ion is required for the amidase activity.
CC       {ECO:0000305|PubMed:8999955}.
CC   -!- MISCELLANEOUS: Gsp hydrolysis to GSH and spermidine proceeds with
CC       formation of a glutathionyl acyl-enzyme intermediate, utilizing a
CC       cysteine residue as the catalytic nucleophile (PubMed:9398217).
CC       For Gsp synthesis, GSH is likely phosphorylated at one of two GSH-
CC       binding sites to form an acylphosphate intermediate that then
CC       translocates to the other site for subsequent nucleophilic
CC       addition of spermidine (PubMed:17124497).
CC       {ECO:0000305|PubMed:17124497, ECO:0000305|PubMed:9398217}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       glutathionylspermidine synthase preATP-grasp family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U23148; AAC43339.1; -; Genomic_DNA.
DR   EMBL; U28377; AAA69155.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76024.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77049.1; -; Genomic_DNA.
DR   PIR; A57538; A57538.
DR   RefSeq; NP_417462.1; NC_000913.3.
DR   RefSeq; WP_001297309.1; NZ_LN832404.1.
DR   PDB; 2IO7; X-ray; 2.70 A; A/B=1-619.
DR   PDB; 2IO8; X-ray; 2.10 A; A/B=1-619.
DR   PDB; 2IO9; X-ray; 2.20 A; A/B=1-619.
DR   PDB; 2IOA; X-ray; 2.80 A; A/B=1-619.
DR   PDB; 2IOB; X-ray; 2.20 A; A/B=1-619.
DR   PDB; 3A2Y; X-ray; 1.95 A; A=1-197.
DR   PDB; 3A2Z; X-ray; 1.50 A; A=1-197.
DR   PDB; 3A30; X-ray; 2.20 A; A=1-197.
DR   PDB; 3O98; X-ray; 2.80 A; A/B=1-619.
DR   PDBsum; 2IO7; -.
DR   PDBsum; 2IO8; -.
DR   PDBsum; 2IO9; -.
DR   PDBsum; 2IOA; -.
DR   PDBsum; 2IOB; -.
DR   PDBsum; 3A2Y; -.
DR   PDBsum; 3A2Z; -.
DR   PDBsum; 3A30; -.
DR   PDBsum; 3O98; -.
DR   ProteinModelPortal; P0AES0; -.
DR   SMR; P0AES0; -.
DR   BioGrid; 4261180; 14.
DR   DIP; DIP-36018N; -.
DR   IntAct; P0AES0; 14.
DR   MINT; MINT-1234290; -.
DR   STRING; 511145.b2988; -.
DR   MEROPS; C51.A01; -.
DR   PaxDb; P0AES0; -.
DR   PRIDE; P0AES0; -.
DR   EnsemblBacteria; AAC76024; AAC76024; b2988.
DR   EnsemblBacteria; BAE77049; BAE77049; BAE77049.
DR   GeneID; 947474; -.
DR   KEGG; ecj:JW2956; -.
DR   KEGG; eco:b2988; -.
DR   PATRIC; 32121392; VBIEscCol129921_3083.
DR   EchoBASE; EB2720; -.
DR   EcoGene; EG12882; gss.
DR   eggNOG; ENOG4106032; Bacteria.
DR   eggNOG; COG0754; LUCA.
DR   HOGENOM; HOG000124980; -.
DR   InParanoid; P0AES0; -.
DR   KO; K01460; -.
DR   OMA; PNHRYLL; -.
DR   BioCyc; EcoCyc:GSP-MONOMER; -.
DR   BioCyc; MetaCyc:GSP-MONOMER; -.
DR   BRENDA; 3.5.1.78; 2026.
DR   BRENDA; 6.3.1.8; 2026.
DR   UniPathway; UPA00204; -.
DR   UniPathway; UPA00819; -.
DR   EvolutionaryTrace; P0AES0; -.
DR   PRO; PR:P0AES0; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008884; F:glutathionylspermidine amidase activity; IDA:EcoCyc.
DR   GO; GO:0008885; F:glutathionylspermidine synthase activity; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006749; P:glutathione metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008216; P:spermidine metabolic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR007921; CHAP_dom.
DR   InterPro; IPR005494; GSPS_pre-ATP-grasp-like_dom.
DR   InterPro; IPR016185; PreATP-grasp_dom.
DR   Pfam; PF05257; CHAP; 1.
DR   Pfam; PF03738; GSP_synth; 1.
DR   SUPFAM; SSF52440; SSF52440; 1.
DR   PROSITE; PS50911; CHAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Ligase; Magnesium;
KW   Metal-binding; Multifunctional enzyme; Nucleotide-binding; Oxidation;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7775463}.
FT   CHAIN         2    619       Bifunctional glutathionylspermidine
FT                                synthetase/amidase.
FT                                /FTId=PRO_0000070443.
FT   DOMAIN       34    176       Peptidase C51. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00048}.
FT   NP_BIND     316    318       ATP.
FT   NP_BIND     539    540       ATP.
FT   NP_BIND     568    571       ATP.
FT   NP_BIND     603    605       ATP.
FT   REGION        2    195       Gsp amidase.
FT   REGION       78     81       Gsp binding.
FT   REGION      196    205       Linker.
FT   REGION      206    619       Gsp synthetase.
FT   ACT_SITE     59     59       S-(gamma-glutamyl-cysteinyl-glycyl)-
FT                                cysteine intermediate.
FT                                {ECO:0000269|PubMed:9398217}.
FT   METAL       318    318       Magnesium 1.
FT   METAL       330    330       Magnesium 1.
FT   METAL       330    330       Magnesium 2.
FT   METAL       332    332       Magnesium 2.
FT   BINDING      58     58       Gsp.
FT   BINDING      64     64       Gsp.
FT   BINDING     149    149       Gsp.
FT   BINDING     316    316       Glutathione.
FT   BINDING     335    335       Glutathione.
FT   BINDING     391    391       Spermidine.
FT   BINDING     392    392       Glutathione.
FT   BINDING     446    446       Glutathione.
FT   BINDING     498    498       ATP.
FT   BINDING     533    533       ATP.
FT   BINDING     582    582       ATP.
FT   BINDING     610    610       Spermidine.
FT   SITE        131    131       Increases nucleophilicity of active site
FT                                Cys; for amidase activity.
FT   SITE        316    316       Transition state stabilizer; for
FT                                synthetase activity.
FT   MOD_RES      59     59       Cysteine sulfenic acid (-SOH); transient.
FT                                {ECO:0000269|PubMed:20530482}.
FT   MUTAGEN      59     59       C->A: Loss of amidase activity.
FT                                {ECO:0000269|PubMed:9398217}.
FT   MUTAGEN     173    173       C->A: No effect on amidase activity.
FT                                {ECO:0000269|PubMed:9398217}.
FT   MUTAGEN     316    316       R->E: Loss of synthetase activity.
FT   MUTAGEN     335    335       S->A: 3.6-fold decrease in GSH affinity,
FT                                1.6-fold decrease in spermidine activity,
FT                                and 1.3-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     337    337       S->A: No effect on GSH and spermidine
FT                                affinity, but 2-fold decrease in
FT                                synthetase activity.
FT                                {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     338    338       C->A: 10-fold decrease in GSH affinity,
FT                                5-fold decrease in spermidine activity,
FT                                but no effect on synthetase activity.
FT                                {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     391    391       E->A: 2-fold decrease in GSH affinity,
FT                                60-fold decrease in spermidine activity,
FT                                and 10-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     392    392       E->A: 33-fold decrease in GSH affinity,
FT                                13-fold decrease in spermidine activity,
FT                                and 6-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     441    441       T->A: 3-fold decrease in GSH affinity,
FT                                21-fold decrease in spermidine activity,
FT                                and 17-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     538    538       R->A: 6-fold decrease in GSH affinity,
FT                                2.4-fold decrease in spermidine activity,
FT                                and 4-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   MUTAGEN     598    598       R->A: 10-fold increase in GSH affinity,
FT                                9-fold decrease in spermidine activity,
FT                                and 15-fold decrease in synthetase
FT                                activity. {ECO:0000269|PubMed:17124497}.
FT   STRAND       15     19       {ECO:0000244|PDB:3A2Z}.
FT   TURN         20     22       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       23     26       {ECO:0000244|PDB:3A2Z}.
FT   HELIX        35     40       {ECO:0000244|PDB:3A2Z}.
FT   HELIX        42     44       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       45     48       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       51     55       {ECO:0000244|PDB:3A2Z}.
FT   HELIX        59     71       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       72     74       {ECO:0000244|PDB:3A2Z}.
FT   HELIX        81     86       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       89     92       {ECO:0000244|PDB:3A2Z}.
FT   TURN         93     95       {ECO:0000244|PDB:3A2Z}.
FT   STRAND       98    100       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      102    105       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      108    110       {ECO:0000244|PDB:2IOB}.
FT   STRAND      117    120       {ECO:0000244|PDB:3A2Z}.
FT   HELIX       124    126       {ECO:0000244|PDB:3A2Z}.
FT   TURN        127    129       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      131    138       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      140    146       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      148    150       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      162    170       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      173    177       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      179    182       {ECO:0000244|PDB:3A2Z}.
FT   STRAND      185    192       {ECO:0000244|PDB:3A2Z}.
FT   HELIX       206    209       {ECO:0000244|PDB:2IO8}.
FT   STRAND      212    215       {ECO:0000244|PDB:2IO8}.
FT   STRAND      229    231       {ECO:0000244|PDB:2IOA}.
FT   HELIX       232    241       {ECO:0000244|PDB:2IO8}.
FT   STRAND      245    247       {ECO:0000244|PDB:2IO8}.
FT   STRAND      251    256       {ECO:0000244|PDB:2IO8}.
FT   HELIX       257    283       {ECO:0000244|PDB:2IO8}.
FT   HELIX       285    288       {ECO:0000244|PDB:2IO8}.
FT   HELIX       289    291       {ECO:0000244|PDB:2IO8}.
FT   HELIX       295    297       {ECO:0000244|PDB:2IO8}.
FT   HELIX       298    307       {ECO:0000244|PDB:2IO8}.
FT   HELIX       309    311       {ECO:0000244|PDB:2IOB}.
FT   STRAND      314    322       {ECO:0000244|PDB:2IO8}.
FT   STRAND      325    332       {ECO:0000244|PDB:2IO8}.
FT   HELIX       339    343       {ECO:0000244|PDB:2IO8}.
FT   HELIX       345    353       {ECO:0000244|PDB:2IO8}.
FT   TURN        361    364       {ECO:0000244|PDB:2IO8}.
FT   HELIX       365    374       {ECO:0000244|PDB:2IO8}.
FT   STRAND      380    386       {ECO:0000244|PDB:2IO8}.
FT   HELIX       390    405       {ECO:0000244|PDB:2IO8}.
FT   STRAND      409    416       {ECO:0000244|PDB:2IO8}.
FT   STRAND      423    425       {ECO:0000244|PDB:2IO8}.
FT   STRAND      437    442       {ECO:0000244|PDB:2IO8}.
FT   HELIX       444    453       {ECO:0000244|PDB:2IO8}.
FT   TURN        456    458       {ECO:0000244|PDB:2IOB}.
FT   STRAND      459    461       {ECO:0000244|PDB:2IOB}.
FT   HELIX       475    479       {ECO:0000244|PDB:2IO8}.
FT   STRAND      485    488       {ECO:0000244|PDB:2IO8}.
FT   HELIX       490    493       {ECO:0000244|PDB:2IO8}.
FT   TURN        494    496       {ECO:0000244|PDB:2IO8}.
FT   HELIX       500    507       {ECO:0000244|PDB:2IO8}.
FT   STRAND      517    520       {ECO:0000244|PDB:2IO8}.
FT   HELIX       523    528       {ECO:0000244|PDB:2IO8}.
FT   STRAND      530    534       {ECO:0000244|PDB:2IO8}.
FT   TURN        539    542       {ECO:0000244|PDB:2IO8}.
FT   STRAND      544    546       {ECO:0000244|PDB:2IO8}.
FT   STRAND      552    555       {ECO:0000244|PDB:2IO8}.
FT   TURN        559    562       {ECO:0000244|PDB:2IO8}.
FT   STRAND      565    569       {ECO:0000244|PDB:2IO8}.
FT   STRAND      579    588       {ECO:0000244|PDB:2IO8}.
FT   STRAND      591    604       {ECO:0000244|PDB:2IO8}.
FT   STRAND      609    612       {ECO:0000244|PDB:2IO8}.
FT   STRAND      614    617       {ECO:0000244|PDB:2IO8}.
SQ   SEQUENCE   619 AA;  70532 MW;  07FB43D8A0B2933C CRC64;
     MSKGTTSQDA PFGTLLGYAP GGVAIYSSDY SSLDPQEYED DAVFRSYIDD EYMGHKWQCV
     EFARRFLFLN YGVVFTDVGM AWEIFSLRFL REVVNDNILP LQAFPNGSPR APVAGALLIW
     DKGGEFKDTG HVAIITQLHG NKVRIAEQNV IHSPLPQGQQ WTRELEMVVE NGCYTLKDTF
     DDTTILGWMI QTEDTEYSLP QPEIAGELLK ISGARLENKG QFDGKWLDEK DPLQNAYVQA
     NGQVINQDPY HYYTITESAE QELIKATNEL HLMYLHATDK VLKDDNLLAL FDIPKILWPR
     LRLSWQRRRH HMITGRMDFC MDERGLKVYE YNADSASCHT EAGLILERWA EQGYKGNGFN
     PAEGLINELA GAWKHSRARP FVHIMQDKDI EENYHAQFME QALHQAGFET RILRGLDELG
     WDAAGQLIDG EGRLVNCVWK TWAWETAFDQ IREVSDREFA AVPIRTGHPQ NEVRLIDVLL
     RPEVLVFEPL WTVIPGNKAI LPILWSLFPH HRYLLDTDFT VNDELVKTGY AVKPIAGRCG
     SNIDLVSHHE EVLDKTSGKF AEQKNIYQQL WCLPKVDGKY IQVCTFTVGG NYGGTCLRGD
     ESLVIKKESD IEPLIVVKK
//
